Physician-Founder and CEO of Predicate AI Labs, focused on developing next-generation health intelligence technologies at the intersection of AI, physiological computing, digital health, medical devices, and edge computing. My expertise includes health technology strategy, product development, clinical innovation, commercialization, strategic partnerships, global health, and early-stage venture development. I advise organizations on emerging technologies, market opportunities, […]
I help biotech CEOs make the commercial decisions that shape enterprise value, long before launch. Here’s the bind I see again and again. A CEO is expected to have commercial answers they’ve never had to give, and to project confidence while the evidence isn’t in yet. The science got the company here. Now the questions […]
Hyoung Lee is a CMC (Chemistry, Manufacturing, and Controls) strategist and chemical development leader with over 20 years of experience in the pharmaceutical industry. He currently leads HIL CMC Consulting LLC, providing strategic guidance on chemical development and CMC-related activities for drug development programs.nnHis expertise spans chemical process development, manufacturing strategy, and quality considerations throughout […]
Mark Fyvie is a biopharma entrepreneur whose career began with a PhD from the University of Cambridge (UK). He has since built extensive experience across the biopharmaceutical industry, spanning research, drug development, and company building. He currently leads Vx Pharma, applying his scientific background and entrepreneurial acumen to assist clinical stage startups advance their therapeutic […]
Jason Moore is a life sciences strategy advisor with experience guiding global life sciences companies on strategic options and leading business initiatives. He supports organizations navigating complex decisions across the life sciences landscape. His expertise spans strategic advisory, business development, and partnerships within the biotech and pharmaceutical sectors. Jason helps clients evaluate growth opportunities, structure […]
David Scieszka is the Founder and CEO of Vertical Longevity Pharmaceuticals, a biotechnology company focused on longevity science and therapeutics. In this role, he leads the company’s strategic vision, research direction, and business development efforts in the emerging longevity biotech space. He completed his PhD in biomedical sciences at The University of New Mexico School […]